SCHEMBL22504967

SCHEMBL22504967

CC(c1oc(=O)c2ccccc2c1-c1cccc(C2CCCN2C(=O)OC(C)(C)C)c1)n1nc(I)c2c(N)ncnc21

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 10/20 0.39
▸ PIK3CG P48736 4/20 0.38
▸ PIK3R1 P27986 1/20 0.38
▸ CSNK1E P49674 1/20 0.38
▸ SRC P12931 12/20 0.38
▸ EGFR P00533 6/20 0.38
▸ ABL1 P00519 5/20 0.38
▸ ABL2 P42684 2/20 0.38
▸ KDR P35968 3/20 0.37
▸ PIK3CA P42336 3/20 0.37
▸ PRKDC P78527 3/20 0.37
▸ PI4KB Q9UBF8 3/20 0.37
▸ HCK P08631 2/20 0.37
▸ PIK3CB P42338 2/20 0.37
▸ MTOR P42345 2/20 0.37
▸ EPHB4 P54760 2/20 0.37
▸ BACE1 P56817 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29641506 1.00 PIK3CD (0.39) PIK3CDPIK3CGPIK3R1CSNK1ESRC
SCHEMBL30679714 0.87 PIK3CD (0.41) PIK3CDPIK3CGPIK3R1CSNK1ESRC
SCHEMBL22504993 0.87 PIK3CD (0.41) PIK3CDPIK3CGPIK3R1CSNK1ESRC
SCHEMBL24494704 0.87 PIK3CD (0.41) PIK3CDPIK3CGPIK3R1CSNK1ESRC
SCHEMBL22505045 0.81 NR1H2 (0.41) —
SCHEMBL29641539 0.81 NR1H2 (0.41) —
SCHEMBL22504952 0.81 PIK3CD (0.41) PIK3CDPIK3CGPIK3R1CSNK1ESRC
SCHEMBL24494691 0.81 PIK3CD (0.41) PIK3CDPIK3CGPIK3R1CSNK1ESRC
Hydrochloric Acid SCHEMBL22498182 0.80 PIK3CD (0.40) PIK3CDPIK3CGPIK3R1CSNK1ESRC
Hydrochloric Acid SCHEMBL30679720 0.80 PIK3CD (0.40) PIK3CDPIK3CGPIK3R1CSNK1ESRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3947384-B1 ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS CHIESI FARM SPA (IT) 2023-11-01 — — EP disclosed
US-20220175784-A1 ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2022-06-09 — — US disclosed
WO-2020200918-A1 ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2020-10-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220175784-A1 ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS PIKFYVE, PDPK1, PIK3R5 PIK3CD 5/4885PIK3CG 13/4885PIK3R1 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback